---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-080475"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2026-07-22T21:26:11+00:00"
generated_at: "2026-07-22T21:28:09.489640+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# China Pharma prices $5M registered direct offering of 2.5M shares at $2/share

## Summary
- Gross proceeds of $5M from sale of 2.5M shares at $2.00 per share.
- FT Global Capital acting as exclusive placement agent; 7% cash fee.
- Net proceeds to be used for working capital and general corporate purposes.
- Investor gets 40% participation right in subsequent financings for 3 months; 91-day lock-up on variable rate transactions.

## SEC filing metadata
- accession: 0001213900-26-080475
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2026-07-22T21:26:11+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390026080475/0001213900-26-080475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390026080475/ea0298921-8k_china.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-080475
- JSON: https://secwatch.observer/filing/0001213900-26-080475.json
- Plain text: https://secwatch.observer/filing/0001213900-26-080475.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.